SMTL ID : 7ru4.1

CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.1: 8 residues within 4Å: Chain A: W.102, D.103 Chain B: Y.50, T.57 Chain C: N.343, A.344, S.371, S.373 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:S.371, C:S.371, C:S.373

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 3 residues within 4Å: Chain C: R.328, P.330, N.331 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:R.328, C:N.331

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhao, F. et al., Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. Iscience (2022)

Release Date

2022-08-24

Peptides

CC6.33 IgG heavy chain Fv: A
CC6.33 IgG kappa chain Fv: B
Spike glycoprotein: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
A

CC6.33 IgG heavy chain Fv

CC6.33 IgG kappa chain Fv

Spike glycoprotein

Related Entries With Identical Sequence